The first hypnotic barbiturate, barbital, was introduced into clinical practice in 1903, followed
by phenobarbital in 1912. 1 In subsequent years, multiple barbiturates were synthesized …

Abstract SARS-CoV-2, the virus that causes COVID-19, has changed the world as we know
it, and continues to do so. How COVID-19 affects people who use drugs, the environments in …

Our Other Prescription Drug Problem The adverse effects of benzodiazepine overuse,
misuse, and addiction continue to go largely unnoticed. Efforts to reduce overprescribing of …

Background Polysubstance use is a common, problematic behavior that increases risk of
harm to self and others. Research suggests that rates may vary based on gender, sex and …

Introduction While polysubstance use has consistently been associated with higher rates of
relapse, few studies have examined subgroups with specific combinations and time course …

Background The study aimed to assess the prevalence and correlates of non-daily and daily
cannabis use among persons 15 years and older in South Africa. Method In a national cross …

Benzodiazepines (BZDs) represent one of the most widely used groups of pharmaceuticals,
but if used for long periods of time they are associated with dependence and an increased …

Objective: Alcohol and cannabis use as well as their simultaneous use are common among
US college students. Reasons for use are proximal predictors of consumption and …

Abstract In United States military veterans, chronic pain represents a risk factor for opioid
and alcohol misuse, yet few studies have examined interactions among chronic pain, opioid …

Introduction Women who use drugs (WWUD) are prime candidates for pre-exposure
prophylaxis (PrEP) due to their elevated risk of acquiring HIV through biological, behavioral …